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Abstract
We describe an inexpensive, low-toxicity and high-yielding method for the production of pure lanosterol
and dihydrolanosterol from the commercially available mixture. Optimum conditions are presented for
the one-pot production of the intermediate 24,25 vicinal diol of lanosterol acetate (via either epoxidation
or hydroxyhalogenation) which is readily separated from the unreacted dihydrolanosterol acetate. The
lanosterol diol can then be converted to pure (>97%) lanosterol. Hypophophorous acid was used for both
the conversion of the epoxide to the diol, and as a catalyst for the hydroxyhalogenation by N-
halosuccinimides of the olefinic bond.
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1. Introduction
Side chain derivatives of lanosterol (3-hydroxy-5-lanosta-8,24-diene, 1a) have been shown
to act as inhibitors of 24(25) sterol methyl transferase, which is an essential enzyme in the sterol
biosynthesis pathway of protozoa, fungi and plants [1]. Because of this activity these
compounds have potential therapeutic applications. Significant chemopreventive activity of
lanosterol against colon carcinogenesis in rat has been reported [2].
Pure lanosterol for bioassay or as a starting material for synthesis is expensive and the usual
starting material for synthesis is a commercial “lanosterol” containing approximately 40-50% of
dihydrolanosterol 2a, as the major impurity as well as other steroids as minor impurities.
Various methods of obtaining pure lanosterol have been reported in the literature but most are
limited in their suitability for scaling-up either by their low yield [3-6] or the toxic or hazardous
nature of the reagents involved [7].
We here report a technically simple method for the production of pure lanosterol in high yield
without recourse to highly toxic reagents. Pure dihydrolanosterol, which is also of interest as a
synthetic starting material [9] is also isolated. The method has evolved from our earlier
development of techniques for efficient synthesis of epimerically pure side-chain derivatives of
lanosterol [8].
2. Experimental
2.1. General
Lanosterol 50-60% was purchased from Sigma and used without any further purification.
Hypophosphorous acid (50 wt.% in water) and all other reagents were purchased from Aldrich
and used as such. Column chromatography was carried out on Merck silica gel (70-250 mesh)
using the eluants indicated. TLC was carried out using Augram Sil G/UV254 plates. All
melting points were obtained on a Reichert-Jung micro-melting point determination apparatus
and are uncorrected. Optical rotations were measured on an Optical Activity Ltd. automatic
polarimeter.
Gas chromatography with flame ionisation detection (GC-FID) was carried out using a
Hewlett-Packard Ultra 2 (25m x 0.33mm) crosslinked phenyl methyl silicone fused silica
capillary column. Conditions used were 55°C (1 min), 30°C min-1 to 200°C, 4°C min-1 to
320°C.
Gas Chromatography with mass spectrometry was carried out using a Hewlett Packard HP 1
cross-linked methyl silicone fused silica capillary column interfaced with a Hewlett-Packard
5970 mass spectrometer (70eV). Conditions used were 200°C (1 min), 30°C min-1 to 260°C,
3oC min-1 to 295°C.
1H and 13C NMR spectra were obtained using a Bruker ADV DRX 400 MHZ spectrometer, in
chloroform-d and referenced to chloroform.
2.2. Acetylation of mixed lanosterols (1a+2a)
This was carried out using commercial lanosterol (80g, 0,187 mol, 50-60% pure) as
previously described [8] to give 3-acetoxy-5-lanost-8,24-diene (1b) and 3-acetoxy-5-
lanost-8-ene (2b) as a colourless solid (72 g), mp 125-129oC. 
 
2.3. 24(R,S)-3-acetoxy-24,25-dihydroxy-5-lanost-8-ene (4)
Compound 4 was prepared by two different routes - epoxidation and hydroxyhalogenation
(hydroxy-bromide or hydroxy-iodide)
2.3.1. Epoxide route to 4
To a solution of the mixed lanosterol acetates 1b and 2b (20 g) (1b = 12.3 g, 2b = 7.7 g by
GC) in dichloromethane (600 mL) a mixture of m-chloroperbenzoic acid (70%) (5.5 g) and
sodium hydrogen carbonate (2.2g, 0.05 mol) was added in following manner: half added at room
temperature over 3h and the remainder at 0oC (ice bath), also over 3 h. The mixture was stirred
vigorously (1 h) and left in a refrigerator overnight. The reaction mixture was diluted with 2-
propanol (500 mL), hypophosphorous acid (20 mL) and water (200 mL). Dichloromethane was
removed by distillation at atmospheric pressure, an additional amount of hypophosphorous acid
(10 mL) added and the mixture heated under reflux (2.5 h). The reaction mixture was poured
into water (1.2 L) and the solid filtered and washed with water. Purification by short column
chromatography (CH2Cl2) yielded dihydrolanosterol acetate, 2b (7.3g, 95% recovery), m.p. 120-
121oC (acetone-methanol, lit.[7] 120-122oC). NMR spectra were identical with the literature
[12]. Further elution with ethyl acetate afforded a stereoisomeric mixture of the diol, 24(R,S)-
3-acetoxy-24,25-dihydroxy-5-lanost-8-ene, 4 , as colourless needles (10.7 g, 82%), m.p. 173-
176oC (lit. [10] 166-169oC or [11] 183-185oC; the melting point depends on proportions of R
and S epimers [8]). Anal. Calcd for C32H54O4: C: 76.44, H: 10.83. Found C: 76.52, H: 10.84.
NMR spectra were assigned by comparison with NMR data for the individual R and S epimers
[8] and gave: 1H NMR  0.98 (3H, s, 19-CH3), 0.67 (3H s, 18-CH3), 1.18 (3H, s, 26-CH3), 1.13
(3H, s, 27-CH3), 2,02 (3H, s, 3-OCOCH3), 1.10-1.36 (2H,m, 23-CH2), 3.32 [1H, d, 24-CH (R-
24 hydroxy) J=6.1 & 6.1 Hz], 3.26 [1H, d, 24-CH (S-24 hydroxy) J=2.0 & 10.0 Hz; 13C NMR 
(R,S): C-16 (28.59, 28.48), C-17 (50.91, 50.83), C-20 (36.60, 37.06), C-21 (18.86, 19.14), C-22
(33.45, 33.90), C-23 (28.73, 29.03), C-24 (79.05, 79.22), C-25 (73.45, 73.50), C-26 (26.85,
26.82), C-27 (23.61, 23.53).
2.3.2. Bromohydroxy route to 4.
To a solution of lanosterol acetates 1b and 2b (10 g) (1b = 6.15 g, 2b = 3.85 g by GC) in
acetone (900 mL), water (15 mL) and hypophosphorous acid [2.7 mL (50% in water)] was
added N-bromosuccinimide (3.04 g, 0.017 mol). The reaction mixture was stirred at room
temperature for 5 min., NaHCO3 (3 g) was added and the mixture concentrated under vacuum.
The residue was dissolved in 2-propanol (300 mL), water (100 mL) and hypophosphorous acid
(7.2 mL, 50% in water). More NaHCO3 (4.5 g) was added, and the reaction mixture was
refluxed (4 h), diluted with water, filtered and washed until neutral. Separation by flash column
chromatography (dichloromethane) yielded dihydrolanosterol acetate, 2b , (3.3 g, 85%), m.p.
119-120oC (twice from acetone; lit.[7] 120-122oC). NMR spectra were as reported [12].
Further elution with ethyl acetate afforded a stereoisomeric mixture of the diol, 24(R,S)-3-
acetoxy-24,25-dihydroxy-5-lanost-8-ene, 4 , as colourless needles (5.8 g, 88%), m.p. 172-
175oC (Lit. [10] 166-169oC or [11] 183-185oC, depending on epimeric composition).
2.3.3. Iodohydroxy route to 4.
The reaction was carried out as described in 2.3.2 with N-iodosuccinimide in place of N-
bromosuccinimide to give 2b , (3.3 g, 81%), m.p. 119-120oC (twice from acetone) and 4 (5.6 g,
86%) m.p. 170-174oC.
2.4. Conversion of 24(R,S)-3-acetoxy-24,25-dihydroxy-5-lanost-8-ene, 4, to lanosterol
acetate, 1b.
To a solution of 24(R,S)-3-acetoxy-24,25-dihydroxy-5-lanost-8-ene (4, 10 g, 0.0199 mol)
in dichloromethane (150 mL) was added N,N-dimethylformamide dimethylacetal (13.2 mL,
0.597 mol) and the mixture was refluxed (2.5 h). The reaction mixture was cooled, acetic
anhydride (20 mL) was added and the dichloromethane was distilled under reduced pressure.
An additional amount of acetic anhydride (100 mL) was added and the mixture containing acetal
6 was refluxed at 130oC (3.5 h), cooled, poured into ice-water and the solid filtered and washed
until neutral to yield a light brown powder. The crude product after chromatography through
silica gel (eluent dichloromethane) afforded lanosterol acetate, 1b, (8.3 g, 90%) as a white
powder (97% purity by GC), m.p. 129.5-131.5oC []D = + 58.6 (c 1.16, CHCl3). [Lit [6,7]
m.p.=129-130oC, []D = + 57.1o (c 1.1, CHCl3) or m.p. = 129-130oC, []D = +59.0o (c 1.0
CHCl3). NMR spectra matched those in the literature [13]. Purification by recrystallisation at
this stage resulted in poor recovery of material, so the crude product was used for the next stage.
2.5.Conversion of lanosterol and dihydrolanosterol acetates (1b and 2b) to the corresponding
hydroxy derivatives (1a and 1b)
Lanosterol acetate (1b, 5 g) was hydrolysed with 10% potassium hydroxide in ethanol (150
mL) at 60oC for 2 h. The resulting mixture was poured into ice water and after standing 6-7 h
was collected by filtration, dried and recrystallised from methanol-benzene to yield 3-hydroxy-
5-lanosta-8,24-diene (1a, 4.2 g, 92%), m.p. 139-140oC, (Lit. [6] 140oC). NMR was identical
with literature [13]. GC-MS analysis indicated a purity of 98% lanosterol with the major
impurity being agnosterol (2%).
Similar treatment of dihydrolanosterol acetate (2b) afforded 3-hydroxy-5-lanosta-8-ene
(2a, 4.25 g, 93%), m.p. 144-145oC, (Lit. [9] 144-144.5oC). NMR was identical with literature
[13]. GC-MS indicated 98.6% dihydrolanosterol and 1.4% of agnosterol.
3. Results and Discussion
Lanosterol has been purified by three different routes, all of which have in common the
formation of 24(R,S)-3-acetoxy-24,25-dihydroxy-5-lanost-8-ene, 4, Scheme 1. In the first
stage, Scheme 1, the epimeric 24,25-epoxylanosterol acetate 3, or 24-halo-25-hydroxylanosterol
acetates, 5a,5b, were formed as a precursor to the diols, 4. Separation from 2b was effected by
short column chromatography at the diol stage (a significant difference between the solubility of
2b and 4 in organic solvents makes this process very easy for large scale production). The
mixture of epimeric diols was then converted via the N,N-dimethylacetal, 6, to lanosterol
acetate, 1a.
In the first method, epoxidation [7, 8] of acetylated commercial lanosterol (mixture of 1b and
2b in the ratio 61.5:38.5) with m-chloroperbenzoic acid afforded a mixture of the epimeric
24,25-epoxylanosterol acetates, 3, which were not isolated. Upon refluxing in 2-propanol and
aqueous hypophosphorous acid the epoxide, 3, afforded the mixed epimers of 24,25-
dihydroxylanosterol acetate, 4. 2-Propanol was chosen as the organic solvent to afford
miscibility with water without competing as a nucleophile and thereby forming unwanted ethers.
Alternatively, treatment of acetylated commercial lanosterol (1b and 2b) with N-
bromosuccinimide (NBS) or N-iodosuccinimide (NIS) in aqueous acetone in the presence of a
catalytic amount of hypophosphorous acid afforded a mixture of the corresponding 24(R,S)-
halo-25-hydroxylanosterol acetates 5a and 5b (c.f. [8]). These were converted directly to the
mixed epimeric diol, 4, by refluxing in 2-propanol with aqueous hypophosphorous acid and its
sodium salt, which was generated in situ by addition of NaHCO3 to the reaction mixture.
Hypophosphorous acid (phosphinic acid, H3PO2) is cheap and readily available, and its
residues are environmentally benign. The remarkable features of the effect of the
hypophosphorous acid are the rapidity of the hydroxyhalogenation reaction, which is complete
in 5 minutes and the high yield of diols obtained, which indicates a very high yield in the
preceding hydroxyhalogenation step.
The diol, 4, was readily converted to lanosterol acetate, 1b, via the N,N-dimethylacetals, 6,
[14]. Assay of 1b before crystallisation indicated about 97% purity (by GC). Hydrolysis of the
acetate 1b generated lanosterol with >98% purity, with agnosterol being the main remaining
contaminant.
The overall four-step process provides pure lanosterol and dihydrolanosterol from the
commercial mixture, with better than 90% yields at each stage. This new method of separation
compares favourably with the yield obtained by Rodewald and Jagodzinski [7] using
environmentally unacceptable mercury (II) acetate and LiAIH4 and is a significant improvement
on other yields quoted in the literature [3-6].
We believe that one pot dihydroxylation reaction of the 24,25-double bond of lanosterol
through hydroxyhalides could be successfully applied to other olefins as well.
Conclusion
A simple, inexpensive and low toxicity route is described for the purification of lanosterol
from mixtures of lanosterol and dihydrolanosterol. The method makes use of two different
routes to a common intermediate 24,25-dihydroxylanosterol acetate, which is then readily
converted to lanosterol. High yields are made possible by the use of hypophosphorous acid as a
reagent for the ring-opening of the intermediate epoxides, or as a catalyst for the
hydroxyhalogenation.
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